Open the map

Agilent TechnologiesA

Life science tools · NYSE · USA

$168.17
Down 0.5% todayClose

Up 24.4% this year and +23.6% since June 26, ahead of the life science sector at +10.7%. Agilent Technologies supplies 2 mapped companies.

Market cap
$46.3B
This year
+24.4%
1 year
+19.6%
P/E
32.1
P/S
6.3
P/B
6.3

Price vs the life science sector

since Jun 26ALife science sector, equal weight
Agilent Technologies (A) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. A: +23.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8A +23.6%Sector +10.7% Agilent Technologies (A) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. A: +23.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8A+23.6%Sector+10.7%

Supply chain

2 customers
SUPPLIERS →→ CUSTOMERSNone mappedAbbVie (ABBV)ABBVAbbVie+0.4%Pfizer (PFE)PFEPfizer−0.6%AAgilent Technol…

Customers 2

Open the full chain →

About Agilent Technologies

Laboratory analysis is the business: LC/MS and other analytical instruments, sold with the consumables and diagnostic reagents that keep them running.

Theme exposure

Analytical instrumentsLife science toolsDiagnostics exposureDiagnostics

Products

  • Analytical instruments (LC/MS)
  • Laboratory consumables
  • Diagnostic reagents

Competitors

Risks

  • Cyclical demand
  • Exposure to the China market

Same segment: Life science tools

Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.

Thermo Fisher ScientificTMO−1.5%DanaherDHR−0.5%Waters CorporationWAT−1.6%IlluminaILMN−1.2%RevvityRVTY−0.9%

Compare A

Side by side with the largest companies in the same segment.

A vs TMOA vs DHRA vs WATA vs ILMNA vs RVTY

See where Agilent Technologies sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →